Cipla eyes South Africa with plans for Cipla Medpro stake

S Radhakrishnan, ED, Cipla explains to CNBC-TV18 that the company is in discussions to acquire a 51 percent stake in Cipla Medpro, South Africa for a consideration of USD 220 million. The acquisition also offers a stake in Cipla Medpro business in South Africa.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney SME Special
moneycontrol.com

Home » News » Business

Nov 21, 2012, 05.04 PM | Source: CNBC-TV18

Cipla eyes South Africa with plans for Cipla Medpro stake

S Radhakrishnan, ED, Cipla explains to CNBC-TV18 that the company is in discussions to acquire a 51 percent stake in Cipla Medpro, South Africa for a consideration of USD 220 million. The acquisition also offers a stake in Cipla Medpro business in South Africa.

Like this story, share it with millions of investors on M3

Cipla eyes South Africa with plans for Cipla Medpro stake

S Radhakrishnan, ED, Cipla explains to CNBC-TV18 that the company is in discussions to acquire a 51 percent stake in Cipla Medpro, South Africa for a consideration of USD 220 million. The acquisition also offers a stake in Cipla Medpro business in South Africa.

Post Your Comments

Share Cancel

The acquisition also allows us a stake in Cipla Medpro’s business in South Africa

- S Radhakrishnan (ED)

S Radhakrishnan, ED, Cipla explains to CNBC-TV18 that the company is in discussions to acquire a 51 percent stake in Cipla Medpro, South Africa for a consideration of USD 220 million. The acquisition also offers a stake in Cipla Medpro business in South Africa.

Below is an edited transcript of the interview on CNBC-TV18

Q: Can you explain the reason for interest in the acquisition and what it entails in terms of financial outlay?

A: To clarify, we are in preliminary discussions and I have made an indicative proposal of acquiring approximately a 51 percent equity stake in Cipla Medpro South Africa and the total outlay for the acquisition of 51 percent will be about USD 220 million. Cipla Medpro substantially procures and markets our products and logically, it is good to now integrate with our frontend and that is why we are proposing to make this acquisition.

Q: What is your current stake in Medpro?

A: We do not have any stake as of now. We supply our products to them which they market.

Q: What is the logic behind this USD 220 million outlay? What would it give you access to in terms of the kind of revenues that you have in South Africa today?

A: We supply products to them and they market the Cipla brand in South Africa. So this really gives us a stake in our own brands in South Africa and the company is worth over USD 200 million. The acquisition also allows us a stake in Cipla Medpro’s business in South Africa.

Q: Can breakdown the financials of the South African business?

A: Roughly, this company is a over-USD 200 million company and posted a bottom-line of USD 40 million last year.

Q: Would the entire USD 220 million be financed from accruals?

A: Yes, it would be financed through accruals.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Cipla eyes South Africa with plans for Cipla Medpro stake

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login